Related references
Note: Only part of the references are listed.Autonous Aldosterone Secretion as a Subclinical Form of Primary Aldosteronism: Pathogenesis and Clinical Significance
Piotr Kmiec et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2022)
Somatic CACNA1H Mutation As a Cause of Aldosterone-Producing Adenoma
Kazutaka Nanba et al.
HYPERTENSION (2020)
Molecular and Electrophysiological Analyses of ATP2B4 Gene Variants in Bilateral Adrenal Hyperaldosteronism
Namita Ganesh Hattangady et al.
HORMONES & CANCER (2020)
Immunohistochemistry of the Human Adrenal CYP11B2 in Normal Individuals and in Patients with Primary Aldosteronism
Celso E. Gomez-Sanchez et al.
HORMONE AND METABOLIC RESEARCH (2020)
Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension*
Paolo Mulatero et al.
JOURNAL OF HYPERTENSION (2020)
Identification of Somatic Mutations in CLCN2 in Aldosterone-Producing Adenomas
Juilee Rege et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2020)
Inherited Forms of Primary Hyperaldosteronism: New Genes, New Phenotypes and Proposition of A New Classification
Luis Gustavo Perez-Rivas et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2019)
Proteomic Landscape of Aldosterone-Producing Adenoma
Marta M. Swierczynska et al.
HYPERTENSION (2019)
Treatment of Primary Aldosteronism With mTORC1 Inhibitors
Beckey Trinh et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Characterization and Gene Expression Analysis of Serum-Derived Extracellular Vesicles in Primary Aldosteronism
Jacopo Burrello et al.
HYPERTENSION (2019)
Evaluation and Management of Primary Hyperaldosteronism
Frances T. Lee et al.
SURGICAL CLINICS OF NORTH AMERICA (2019)
Primary Aldosteronism Diagnosis and Management A Clinical Approach
Gregory L. Hundemer et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2019)
Molecular Mechanisms of Primary Aldosteronism
Sergei G. Tevosian et al.
ENDOCRINOLOGY AND METABOLISM (2019)
Regulation of aldosterone production by ion channels: From basal secretion to primary aldosteronism
Tingting Yang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Prevalence of primary aldosteronism in primary care: a cross-sectional study
Sabine C. Kayser et al.
BRITISH JOURNAL OF GENERAL PRACTICE (2018)
The expanding genetic horizon of primary aldosteronism
Silvia Monticone et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Diagnosis and management of primary aldosteronism: the Endocrine Society guideline 2016 revisited
Tracy Ann Williams et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Renal Outcomes in Medically and Surgically Treated Primary Aldosteronism
Gregory L. Hundemer et al.
HYPERTENSION (2018)
CLCN2 chloride channel mutations in familial hyperaldosteronism type II
Ute I. Scholl et al.
NATURE GENETICS (2018)
A gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism
Fabio L. Fernandes-Rosa et al.
NATURE GENETICS (2018)
CLC CHLORIDE CHANNELS AND TRANSPORTERS: STRUCTURE, FUNCTION, PHYSIOLOGY, AND DISEASE
Thomas J. Jentsch et al.
PHYSIOLOGICAL REVIEWS (2018)
The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment
Anand Vaidya et al.
ENDOCRINE REVIEWS (2018)
Genetic aspects of primary hyperaldosteronism
Weronika Korzynska et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2018)
Histopathological Classification of Cross-Sectional Image-Negative Hyperaldosteronism
Yuto Yamazaki et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Is Primary Aldosteronism Still Largely Unrecognized?
Fabrizio Buffolo et al.
HORMONE AND METABOLIC RESEARCH (2017)
Aldosterone-Producing Cell Clusters in Normal and Pathological States
Kei Omata et al.
HORMONE AND METABOLIC RESEARCH (2017)
New gain-of-function mutation shows CACNA1D as recurrently mutated gene in autism spectrum disorders and epilepsy
Alexandra Pinggera et al.
HUMAN MOLECULAR GENETICS (2017)
Old and New Concepts in the Molecular Pathogenesis of Primary Aldosteronism
Elke Tatjana Aristizabal Prada et al.
HYPERTENSION (2017)
Macrolides selectively inhibit mutant KCNJ5 potassium channels that cause aldosterone-producing adenoma
Ute I. Scholl et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Familial hyperaldosteronism type III
S. Monticone et al.
JOURNAL OF HUMAN HYPERTENSION (2017)
Age-Related Autonomous Aldosteronism
Kazutaka Nanba et al.
CIRCULATION (2017)
SFE/SFHTA/AFCE consensus on primary aldosteronism, part 5: Genetic diagnosis of primary aldosteronism
Maria-Christina Zennaro et al.
ANNALES D ENDOCRINOLOGIE (2016)
CACNA1HM1549V Mutant Calcium Channel Causes Autonomous Aldosterone Production in HAC15 Cells and Is Inhibited by Mibefradil
Esther N. Reimer et al.
ENDOCRINOLOGY (2016)
A Novel Phenotype of Familial Hyperaldosteronism Type III: Concurrence of Aldosteronism and Cushing's Syndrome
Anli Tong et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Human Adrenocortical Remodeling Leading to Aldosterone-Producing Cell Cluster Generation
Koshiro Nishimoto et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2016)
Activating mutations in CTNNB1 in aldosterone producing adenomas
Tobias Akerstrom et al.
SCIENTIFIC REPORTS (2016)
CACNA1H Mutations Are Associated With Different Forms of Primary Aldosteronism
Georgios Daniil et al.
EBIOMEDICINE (2016)
ARMC5 mutation analysis in patients with primary aldosteronism and bilateral adrenal lesions
P. Mulatero et al.
JOURNAL OF HUMAN HYPERTENSION (2016)
Novel somatic mutations in primary hyperaldosteronism are related to the clinical, radiological and pathological phenotype
Ute I. Scholl et al.
CLINICAL ENDOCRINOLOGY (2015)
KCNJ5 Mutations Are the Most Frequent Genetic Alteration in Primary Aldosteronism
Tracy A. Williams et al.
HYPERTENSION (2015)
Genetic and Potential Autoimmune Triggers of Primary Aldosteronism
Tracy Ann Williams et al.
HYPERTENSION (2015)
Clinical Characteristics of Somatic Mutations in Chinese Patients With Aldosterone-Producing Adenoma
Fang-Fang Zheng et al.
HYPERTENSION (2015)
ARMC5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia: Clinical and Functional Consequences
Stephanie Espiard et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
A Meta-Analysis of Somatic KCNJ5 K+ Channel Mutations In 1636 Patients With an Aldosterone-Producing Adenoma
Livia Lenzini et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Primary Aldosteronism and ARMC5 Variants
Mihail Zilbermint et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism
Ute I. Scholl et al.
ELIFE (2015)
A review of the prevalence of primary aldosteronism in pre-hypertension and hypertension
George Piaditis et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
The Renin-Angiotensin-Aldosterone System and Heart Failure
Gabriel Sayer et al.
CARDIOLOGY CLINICS (2014)
Pharmacology and Pathophysiology of Mutated KCNJ5 Found in Adrenal Aldosterone-Producing Adenomas
P. Tauber et al.
ENDOCRINOLOGY (2014)
Aldosterone and the kidney: a rapidly moving frontier (an update)
Eberhard Ritz et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease
Andreas Tomaschitz et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2014)
A Novel Y152C KCNJ5 Mutation Responsible for Familial Hyperaldosteronism Type III
Silvia Monticone et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism
Ute I. Scholl et al.
NATURE GENETICS (2013)
Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension
Felix Beuschlein et al.
NATURE GENETICS (2013)
A New Presentation of the Chimeric CYP11B1/CYP11B2 Gene With Low Prevalence of Primary Aldosteronism and Atypical Gene Segregation Pattern
Cristian A. Carvajal et al.
HYPERTENSION (2012)
A Novel Point Mutation in the KCNJ5 Gene Causing Primary Hyperaldosteronism and Early-Onset Autosomal Dominant Hypertension
Evangelia Charmandari et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5
Ute I. Scholl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Prevalence and Characteristics of Familial Hyperaldosteronism The PATOGEN Study (Primary Aldosteronism in TOrino-GENetic forms)
Paolo Mulatero et al.
HYPERTENSION (2011)
A de novo unequal cross-over mutation between CYP11B1 and CYP11B2 genes causes familial hyperaldosteronism type I
C. A. Carvajal et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2011)
Further study of chromosome 7p22 to identify the molecular basis of familial hyperaldosteronism type II
K. J. Carss et al.
JOURNAL OF HUMAN HYPERTENSION (2011)
Differential diagnosis of primary aldosteronism subtypes
Paolo Mulatero et al.
CURRENT HYPERTENSION REPORTS (2009)
A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism
David S. Geller et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
A new form of hereditary primary aldosteronism: Familial hyperaldosteronism type III
Paolo Mulatero
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Mutations of β-catenin in adrenocortical tumors:: Activation of the wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors
F Tissier et al.
CANCER RESEARCH (2005)
Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity
A So et al.
JOURNAL OF HYPERTENSION (2005)
Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism
F Fallo et al.
JOURNAL OF HUMAN HYPERTENSION (2004)
Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps
EE Strehler et al.
PHYSIOLOGICAL REVIEWS (2001)
Share Paper
